US Stock MarketDetailed Quotes

NONOF NOVO NORDISK A/S

Watchlist
  • 136.860
  • +1.060+0.78%
15min DelayClose Aug 23 16:00 ET
609.34BMarket Cap45.76P/E (TTM)

NOVO NORDISK A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NOVO NORDISK A/S Q2 2024 Earnings Date

Currency：DKKAug 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
68.56B
68.06B
-503.19M
Miss Est.
+26.27%
+25.34%
-0.73%
EPS
--
4.49
--
+3.94%
Analyst Rating
No Data

NOVO NORDISK A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 5, 20252024/Q4-- / 82.374B--
Nov 6, 20242024/Q3-- / 73.624B--
Aug 7, 20242024/Q268.060B / 68.563B--
May 2, 20242024/Q165.349B / 63.573B--
Jan 31, 20242023/Q465.863B / 61.207B--
DatePeriodRevenue/EstimateEarnings Call
Feb 5, 20252024/Q4-- / 82.374B--
Nov 6, 20242024/Q3-- / 73.624B--
Aug 7, 20242024/Q268.060B / 68.563B--
May 2, 20242024/Q165.349B / 63.573B--
Jan 31, 20242023/Q465.863B / 61.207B--

Unlock Free Earnings Estimates

NOVO NORDISK A/S Earnings Reports

  • 6-K: Financial Report for the Period 1 January 2024 to 30 June 2024

    Aug 7 06:56 ET

  • 6-K: Novo Nordisk Stops the Ocedurenone CLARION-CKD Trial and Recognises Impairment Loss

    Jun 26 13:22 ET

  • 6-K: Financial Report for the Period 1 January 2024 to 31 March 2024

    May 2 07:18 ET

  • NOVO NORDISK A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 31 07:03 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg